Our specialty pharmaceuticals, branded generics and consumer products play a role in helping millions of people live healthier lives and providing treatment to those affected by debilitating diseases. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and bringing value to our shareholders.

Stock Performance

Recent Events

UBS Global Healthcare Conference


Bank of America Merrill Lynch 2017 Healthcare Conference


Q1 2017 Earnings Results


General Investor Relations
Elif McDonald
Director, Investor Relations
Email: ir@valeant.com
514-856-3855 (Canada)